1. Home
  2. MNKD vs LKFN Comparison

MNKD vs LKFN Comparison

Compare MNKD & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • LKFN
  • Stock Information
  • Founded
  • MNKD 1991
  • LKFN 1872
  • Country
  • MNKD United States
  • LKFN United States
  • Employees
  • MNKD N/A
  • LKFN N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • LKFN Major Banks
  • Sector
  • MNKD Health Care
  • LKFN Finance
  • Exchange
  • MNKD Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • MNKD 1.7B
  • LKFN 1.7B
  • IPO Year
  • MNKD 2004
  • LKFN 1997
  • Fundamental
  • Price
  • MNKD $5.72
  • LKFN $63.61
  • Analyst Decision
  • MNKD Strong Buy
  • LKFN Buy
  • Analyst Count
  • MNKD 5
  • LKFN 2
  • Target Price
  • MNKD $10.80
  • LKFN $68.00
  • AVG Volume (30 Days)
  • MNKD 3.8M
  • LKFN 110.5K
  • Earning Date
  • MNKD 11-06-2025
  • LKFN 10-27-2025
  • Dividend Yield
  • MNKD N/A
  • LKFN 3.12%
  • EPS Growth
  • MNKD 149.32
  • LKFN N/A
  • EPS
  • MNKD 0.11
  • LKFN 3.67
  • Revenue
  • MNKD $301,736,000.00
  • LKFN $239,375,000.00
  • Revenue This Year
  • MNKD $16.36
  • LKFN $16.89
  • Revenue Next Year
  • MNKD $20.34
  • LKFN $4.98
  • P/E Ratio
  • MNKD $52.68
  • LKFN $17.49
  • Revenue Growth
  • MNKD 21.48
  • LKFN N/A
  • 52 Week Low
  • MNKD $3.38
  • LKFN $50.00
  • 52 Week High
  • MNKD $7.63
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 63.58
  • LKFN 43.98
  • Support Level
  • MNKD $5.33
  • LKFN $60.51
  • Resistance Level
  • MNKD $5.90
  • LKFN $65.43
  • Average True Range (ATR)
  • MNKD 0.21
  • LKFN 1.72
  • MACD
  • MNKD -0.02
  • LKFN -0.18
  • Stochastic Oscillator
  • MNKD 77.46
  • LKFN 50.48

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: